← Open Payments lookup

OGHALE MUKORO: Open Payments

NPI 1437666591 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,550 in 119 payments from 17 companies in 2025. Trend: 2023 $1,557 · 2024 $1,709 · 2025 $2,550

Food & beverage: $2,550
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$439
Otsuka America Pharmaceutical, Inc.16$281
Axsome Therapeutics, Inc.7$223
ABBVIE INC.11$209
Takeda Pharmaceuticals U.S.A., Inc.9$198
Teva Pharmaceuticals USA, Inc.11$187
Neurocrine BioSciences, Inc.8$178
Alkermes, Inc.7$172
E.R. Squibb & Sons, L.L.C.7$153
Lundbeck LLC7$135

Products named: CAPLYTA, REXULTI, Auvelity, VRAYLAR, TRINTELLIX, INGREZZA, ARISTADA, COBENFY.

Industry payments across TX — which companies pay providers there.